title: HLA B62 as a possible risk factor for drug reaction with eosinophilia and systemic symptoms to piperacillin/tazobactam.
authors.affiliation: Department of Allergy, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. Electronic address: chris.rutkowski@gstt.nhs.uk.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Rutkowski
authors.affiliation: Tissue Typing Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
authors.forename: Craig
authors.initials: C
authors.lastname: Taylor
authors.affiliation: Department of Allergy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
authors.forename: Annette
authors.initials: A
authors.lastname: Wagner
mesh_terms: D000328:Adult; D000368:Aged; D000485:Allergens / Q000276:immunology / Q000627:therapeutic use*; D063926:Drug Hypersensitivity Syndrome / Q000235:genetics*; D005260:Female; D015235:HLA-B Antigens / Q000235:genetics*; D006650:Histocompatibility Testing; D006801:Humans; D006968:Hypersensitivity, Delayed; D008297:Male; D008875:Middle Aged; D010878:Piperacillin / Q000276:immunology / Q000627:therapeutic use*; D012307:Risk Factors; D012882:Skin Tests; D000078142:Tazobactam / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D000485:Allergens; D015235:HLA-B Antigens; D000078142:Tazobactam; D010878:Piperacillin